In pancreatic cancer, decreased levelsof PCNA were linked with alterations in the NRF2 pathway, while alterationsin the MYC/MYCN and HIPPO pathways was linked with increased PCNAlevels in lung and pancreatic cancer. Here, MYCN is linked to pancreatic neoplasm.